163 related articles for article (PubMed ID: 18688907)
21. Novel and potent inhibitors of 5-lipoxygenase product synthesis based on the structure of pirinixic acid.
Werz O; Greiner C; Koeberle A; Hoernig C; George S; Popescu L; Syha I; Schubert-Zsilavecz M; Steinhilber D
J Med Chem; 2008 Sep; 51(17):5449-53. PubMed ID: 18710209
[TBL] [Abstract][Full Text] [Related]
22. Multitarget drugs: synthesis and preliminary pharmacological characterization of zileuton analogues endowed with Dual 5-LO inhibitor and NO-dependent activities.
Boschi D; Giorgis M; Cena C; Talniya NC; Di Stilo A; Morini G; Coruzzi G; Guaita E; Fruttero R; Gasco A
ChemMedChem; 2010 Sep; 5(9):1444-9. PubMed ID: 20645382
[No Abstract] [Full Text] [Related]
23. Dual inhibitory activities of tannins from Hamamelis virginiana and related polyphenols on 5-lipoxygenase and lyso-PAF: acetyl-CoA acetyltransferase.
Hartisch C; Kolodziej H; von Bruchhausen F
Planta Med; 1997 Apr; 63(2):106-10. PubMed ID: 9140221
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase.
Sinha S; Doble M; Manju SL
Eur J Med Chem; 2018 Oct; 158():34-50. PubMed ID: 30199704
[TBL] [Abstract][Full Text] [Related]
25. Cannabidiol-2',6'-dimethyl ether, a cannabidiol derivative, is a highly potent and selective 15-lipoxygenase inhibitor.
Takeda S; Usami N; Yamamoto I; Watanabe K
Drug Metab Dispos; 2009 Aug; 37(8):1733-7. PubMed ID: 19406952
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of leukotriene production by inhibitors of lipoxygenation.
Garland LG; Hodgson ST
Adv Prostaglandin Thromboxane Leukot Res; 1994; 22():33-48. PubMed ID: 7771347
[No Abstract] [Full Text] [Related]
27. Synthesis and Biological Evaluation of N-Aryl-5-aryloxazol-2-amine Derivatives as 5-Lipoxygenase Inhibitors.
Suh JH; Yum EK; Cho YS
Chem Pharm Bull (Tokyo); 2015; 63(8):573-8. PubMed ID: 26040270
[TBL] [Abstract][Full Text] [Related]
28. The anti-inflammatory effects of ZLJ-6, a novel dual cyclooxygenase/5-lipoxygenase inhibitor.
Li L; Ji H; Sheng L; Zhang Y; Lai Y; Chen X
Eur J Pharmacol; 2009 Apr; 607(1-3):244-50. PubMed ID: 19243697
[TBL] [Abstract][Full Text] [Related]
29. A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors.
Hofmann B; Barzen S; Rödl CB; Kiehl A; Borig J; Zivković A; Stark H; Schneider G; Steinhilber D
J Med Chem; 2011 Mar; 54(6):1943-7. PubMed ID: 21341744
[TBL] [Abstract][Full Text] [Related]
30. Optimization of benzoquinone and hydroquinone derivatives as potent inhibitors of human 5-lipoxygenase.
Peduto A; Scuotto M; Krauth V; Roviezzo F; Rossi A; Temml V; Esposito V; Stuppner H; Schuster D; D'Agostino B; Schiraldi C; de Rosa M; Werz O; Filosa R
Eur J Med Chem; 2017 Feb; 127():715-726. PubMed ID: 27836196
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure-activity relationship studies of novel dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase.
Meirer K; Rödl CB; Wisniewska JM; George S; Häfner AK; Buscató EL; Klingler FM; Hahn S; Berressem D; Wittmann SK; Steinhilber D; Hofmann B; Proschak E
J Med Chem; 2013 Feb; 56(4):1777-81. PubMed ID: 23356879
[TBL] [Abstract][Full Text] [Related]
32. Development of 3,5-dinitrobenzoate-based 5-lipoxygenase inhibitors.
Shang E; Liu Y; Wu Y; Zhu W; He C; Lai L
Bioorg Med Chem; 2014 Apr; 22(8):2396-402. PubMed ID: 24685113
[TBL] [Abstract][Full Text] [Related]
33. Chemical constituents of Melandrium firmum Rohrbach and their anti-inflammatory activity.
Zheng MS; Hwang NK; Kim DH; Moon TC; Son JK; Chang HW
Arch Pharm Res; 2008 Mar; 31(3):318-22. PubMed ID: 18409044
[TBL] [Abstract][Full Text] [Related]
34. Development of a fluorescence-based enzyme assay of human 5-lipoxygenase.
Pufahl RA; Kasten TP; Hills R; Gierse JK; Reitz BA; Weinberg RA; Masferrer JL
Anal Biochem; 2007 May; 364(2):204-12. PubMed ID: 17376394
[TBL] [Abstract][Full Text] [Related]
35. Pyrazole-based sulfonamide and sulfamides as potent inhibitors of mammalian 15-lipoxygenase.
Ngu K; Weinstein DS; Liu W; Langevine C; Combs DW; Zhuang S; Chen X; Madsen CS; Harper TW; Ahmad S; Robl JA
Bioorg Med Chem Lett; 2011 Jul; 21(14):4141-5. PubMed ID: 21696952
[TBL] [Abstract][Full Text] [Related]
36. Substituted coumarins as potent 5-lipoxygenase inhibitors.
Grimm EL; Brideau C; Chauret N; Chan CC; Delorme D; Ducharme Y; Ethier D; Falgueyret JP; Friesen RW; Guay J; Hamel P; Riendeau D; Soucy-Breau C; Tagari P; Girard Y
Bioorg Med Chem Lett; 2006 May; 16(9):2528-31. PubMed ID: 16464579
[TBL] [Abstract][Full Text] [Related]
37. In vitro anti-inflammatory activity of larch (Larix decidua L.) sawdust.
Pferschy-Wenzig EM; Kunert O; Presser A; Bauer R
J Agric Food Chem; 2008 Dec; 56(24):11688-93. PubMed ID: 19049343
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of pyrimido[4,5-b][1,4]benzothiazine derivatives, as potent 15-lipoxygenase inhibitors.
Bakavoli M; Nikpour M; Rahimizadeh M; Saberi MR; Sadeghian H
Bioorg Med Chem; 2007 Mar; 15(5):2120-6. PubMed ID: 17210254
[TBL] [Abstract][Full Text] [Related]
39. Rationalization of physicochemical characters of 1,5-diarylpyrazole analogs as dual (COX-2/LOX-5) inhibitors: a QSAR approach.
Revathi S; Gupta AK; Soni LK; Kavitha S; Wagh R; Kaskhedikar SG
J Pharm Biomed Anal; 2006 Sep; 42(2):283-9. PubMed ID: 16781106
[TBL] [Abstract][Full Text] [Related]
40. Anti-inflammatory potential and fatty acid content of lipophilic leaf extracts of four Staphylea L. species.
Lacikova L; Pferschy-Wenzig EM; Masterova I; Grancai D; Bauer R
Nat Prod Commun; 2009 Apr; 4(4):543-6. PubMed ID: 19476002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
